Toggle navigation
Home
Search
Services
Blog
Contact
About
Vascular Chemokine Receptor CXCR-4 - Molecular Signaling
Shockley, Melinda S.
University of Pennsylvania, Philadelphia, PA, United States
Search grants from Melinda Shockley
Search grants from University of Pennsylvania
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Staphylococcus aureus resistance to topical antimicrobial agents in children
Development of biglycan as a therapeutic for Duchenne Muscular Dystrophy
Primary Care Nurse Clinician Program
Studies in Patients with Partial Seizures
Testing of a Solar Wind-Atmospheric Electricity-Weather and Climate Mechanism
Recently added grants:
Pitt-Ohio State Clinical Trials Unit
Aurum South and East African Clinical Trials Unit
GHESKIO Clinical Trials Unit
HIV Centers for Underrepresented Populations in Research Clinical Trials Unit (CURE CTU)
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32HL009944-01
Application #
2536100
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Project Start
1998-05-30
Project End
Budget Start
1997-11-27
Budget End
1998-11-26
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
University of Pennsylvania
Department
Pharmacology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Related projects
NIH 1999
F32 HL
Vascular Chemokine Receptor CXCR-4 - Molecular Signaling
Shockley, Melinda S. / University of Pennsylvania
NIH 1998
F32 HL
Vascular Chemokine Receptor CXCR-4 - Molecular Signaling
Shockley, Melinda S. / University of Pennsylvania
Comments
Be the first to comment on Melinda Shockley's grant